Ysios Capital closes its third fund at €216 million ($260 million)

by Ysios Capital

YBF III – Ysios’ largest fund to date – provides biotech ventures with the resources to develop novel and disruptive therapies for indications with high-unmet medical need, supporting pioneering...

Read more

King & Wood Mallesons advises Ysios Capital on the launch of this third fund, Ysios BioFund III

by King & Wood Mallesons

The Funds team of King & Wood Mallesons ("KWM") is advising Ysios Capital ("Ysios") on the launch of its third fund, Ysios BioFund III, with a committed amount of €155 million and a final target siz...

Read more

Ysios Capital presents its third fund of € 200M

by Ysios Capital

Ysios BioFund III will invest in companies that develop disruptive therapeutic products and platform technologies to address clear medical needs following an investment policy similar to its predecess...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Sherpa Capital apuesta por el sector de ...

by Sherpa Capital

Sherpa Capital, firma de capital privado especializada en inversiones ...

Photos Stream